WHO:World Health Organization - The Global Burden of Disease - 2004 Update. WHO Library, Geneva, Switzerland; 2004.
Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349: 1436–1442.
Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55: 580–592.
Michelson D, Stratakis C, Hill L, Reynolds J, Galliven E, Chrousos G, Gold P: Bone mineral density in women with depression. N Engl J Med 1996, 335: 1176–1181.
Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ: Association between depression and mortality in older adults: the cardiovascular health study. Arch Intern Med 2000, 160: 1761–1768.
Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML: Depression as an antecedent to heart disease among women and men in the NHANES I study. National health and nutrition examination survey. Arch Intern Med 2000, 160: 1261–1268.
Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F: Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49: 837–845.
Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003, 4: 819–828.
Belmaker RH, Agam G: Major depressive disorder. N Engl J Med 2008, 358: 55–68.
Kendler KS, Prescott CA, Myers J, Neale MC: The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 2003, 60: 929–937.
Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB: Gender differences in chronic major and double depression. J Affect Disord 2000, 60: 1–11.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005, 62: 593–602.
Angst J, Dobler-Mikola A: Do the diagnostic criteria determine the sex ratio in depression? J Affect Disord 1984, 7: 189–198.
Frank E, Carpenter LL, Kupfer DJ: Sex differences in recurrent depression: are there any that are significant? Am J Psychiatry 1988, 145: 41–45.
Young MA, Fogg LF, Scheftner WA, Keller MB, Fawcett JA: Sex differences in the lifetime prevalence of depression: does varying the diagnostic criteria reduce the female/male ratio? J Affect Disord 1990, 18: 187–192.
Silverstein B: Gender difference in the prevalence of clinical depression: the role played by depression associated with somatic symptoms. Am J Psychiatry 1999, 156: 480–482.
Najt P, Fusar-Poli P, Brambilla P: Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Res 2011, 186: 159–164.
Weissman MM, Klerman GL: Sex-differences and epidemiology of depression. Arch Gen Psychiatry 1977, 34: 98–111.
Bogner HR, Gallo JJ: Are higher rates of depression in women accounted for by differential symptom reporting? Soc Psychiatry Psychiatr Epidemiol 2004, 39: 126–132.
Hamilton JA, Grant M, Jensvold MF: Sex and treatment of depression: When does it matter? In Psychopharmacology and Women: Sex, Gender, and Hormones. Edited by: Jensvold MF, Halbreich U, Hamilton JA. American Psychiatric Press, Washington, DC; 1996:241–257.
Quitkin FM, Stewart JW, McGrath PJ, Taylor BP, Tisminetzky MS, Petkova E, Chen Y, Ma G, Klein DF: Are there differences between women’s and men’s antidepressant responses? Am J Psychiatry 2002, 159: 1848–1854.
Entsuah AR, Huang H, Thase ME: Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001, 62: 869–877.
Kelly MM, Tyrka AR, Anderson GM, Price LH, Carpenter LL: Sex differences in emotional and physiological responses to the trier social stress test. J Behav Ther Exp Psychiatry 2008, 39: 87–98.
Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S: Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004, 22: 409–418.
Mayberg HS: Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997, 9: 471–481.
Gaiteri C, Guilloux JP, Lewis DA, Sibille E: Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression. PLoS One 2010, 5: e9970.
Martin EI, Ressler KJ, Binder E, Nemeroff CB: The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med 2010, 30: 865–891.
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR: 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8: 828–834.
Drevets WC, Ongur D, Price JL: Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression. Mol Psychiatry 1998, 3: 190–191.
Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA: Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000, 48: 830–843.
Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME: Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 2007, 61: 198–209.
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH: Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45: 651–660.
Craig AD: How do you feel–now? The anterior insula and human awareness. Nat Rev Neurosci 2009, 10: 59–70.
Drevets WC, Savitz J, Trimble M: The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 2008, 13: 663–681.
Vogt BA: Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 2005, 6: 533–544.
Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS: Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 2002, 51: 693–707.
Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA: Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001, 50: 651–658.
Townsend JD, Eberhart NK, Bookheimer SY, Eisenberger NI, Foland-Ross LC, Cook IA, Sugar CA, Altshuler LL: fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder. Psychiatry Res 2010, 183: 209–217.
Monk CS, Klein RG, Telzer EH, Schroth EA, Mannuzza S, Moulton JL 3rd, Guardino M, Masten CL, McClure-Tone EB, Fromm S, Blair RJ, Pine DS, Ernst M: Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 2008, 165: 90–98.
Engel K, Bandelow B, Gruber O, Wedekind D: Neuroimaging in anxiety disorders. J Neural Transm 2009, 116: 703–716.
Pothion S, Bizot JC, Trovero F, Belzung C: Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 2004, 155: 135–146.
Muscat R, Willner P: Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev 1992, 16: 507–517.
Papp M, Willner P, Muscat R: An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 1991, 104: 255–259.
Ducottet C, Aubert A, Belzung C: Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice. Behav Brain Res 2004, 155: 291–299.
Groenink L, Dirks A, Verdouw PM, Schipholt M, Veening JG, van der Gugten J, Olivier B: HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol Psychiatry 2002, 51: 875–881.
Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF: Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973, 28: 19–24.
O’Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N: A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 2004, 161: 2081–2090.
Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G: A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984, 19: 1215–1228.
Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I: Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 1997, 82: 234–238.
Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G, Belzung C, Sibille E: Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009, 34: 1363–1380.
Willner P: Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiatry 1986, 10: 677–690.
Berger M, Bossert S, Krieg JC, Dirlich G, Ettmeier W, Schreiber W, von Zerssen D: Interindividual differences in the susceptibility of the cortisol system: an important factor for the degree of hypercortisolism in stress situations? Biol Psychiatry 1987, 22: 1327–1339.
Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ: Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9: 519–525.
Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ: Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131: 391–404.
Shimamoto A, Debold JF, Holly EN, Miczek KA: Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse. Psychopharmacology (Berl) 2011, 218: 271–279.
Holly EN, Shimamoto A, Debold JF, Miczek KA: Sex differences in behavioral and neural cross-sensitization and escalated cocaine taking as a result of episodic social defeat stress in rats. Psychopharmacology (Berl) 2012, 224: 179–188.
Bourke CH, Neigh GN: Exposure to repeated maternal aggression induces depressive-like behavior and increases startle in adult female rats. Behav Brain Res 2012, 227: 270–275.
Trainor BC, Pride MC, Villalon Landeros R, Knoblauch NW, Takahashi EY, Silva AL, Crean KK: Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse ( Peromyscus californicus ). PLoS One 2011, 6: e17405.
Trainor BC, Takahashi EY, Campi KL, Florez SA, Greenberg GD, Laman-Maharg A, Laredo SA, Orr VN, Silva AL, Steinman MQ: Sex differences in stress-induced social withdrawal: independence from adult gonadal hormones and inhibition of female phenotype by corncob bedding. Horm Behav 2013, 63: 543–550.
Seligman ME, Beagley G: Learned helplessness in the rat. J Comp Physiol Psychol 1975, 88: 534–541.
Chourbaji S, Zacher C, Sanchis-Segura C, Dormann C, Vollmayr B, Gass P: Learned helplessness: validity and reliability of depressive-like states in mice. Brain Res Brain Res Protoc 2005, 16: 70–78.
Dalla C, Edgecomb C, Whetstone AS, Shors TJ: Females do not express learned helplessness like males do. Neuropsychopharmacology 2008, 33: 1559–1569.
Chourbaji S, Pfeiffer N, Dormann C, Brandwein C, Fradley R, Sheardown M, Gass P: The suitability of 129SvEv mice for studying depressive-like behaviour: both males and females develop learned helplessness. Behav Brain Res 2010, 211: 105–110.
Arnold AP: The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm Behav 2009, 55: 570–578.
Arnold AP: Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J Neuroendocrinol 2009, 21: 377–386.
McCarthy MM, Arnold AP: Reframing sexual differentiation of the brain. Nat Neurosci 2011, 14: 677–683.
McCarthy MM, Wright CL, Schwarz JM: New tricks by an old dogma: mechanisms of the organizational/activational hypothesis of steroid-mediated sexual differentiation of brain and behavior. Horm Behav 2009, 55: 655–665.
Baum MJ: Differentiation of coital behavior in mammals: a comparative analysis. Neurosci Biobehav Rev 1979, 3: 265–284.
Arnold AP, Breedlove SM: Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm Behav 1985, 19: 469–498.
Schulz KM, Molenda-Figueira HA, Sisk CL: Back to the future: the organizational-activational hypothesis adapted to puberty and adolescence. Horm Behav 2009, 55: 597–604.
Arnold AP, Chen X, Itoh Y: What a difference an X or Y makes: sex chromosomes, gene dose, and epigenetics in sexual differentiation. Handb Exp Pharmacol 2012, 259: 2–9.
Jacobs PA, Strong JA: A case of human intersexuality having a possible XXY sex-determining mechanism. Nature 1959, 183: 302–303.
Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN: A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346: 240–244.
Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R: Male development of chromosomally female mice transgenic for Sry. Nature 1991, 351: 117–121.
Arnold AP, Chen X: What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol 2009, 30: 1–9.
Ikeda Y, Shen WH, Ingraham HA, Parker KL: Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 1994, 8: 654–662.
Parker KL, Schimmer BP: Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 1997, 18: 361–377.
Budefeld T, Grgurevic N, Tobet SA, Majdic G: Sex differences in brain developing in the presence or absence of gonads. Dev Neurobiol 2008, 68: 981–995.
Budefeld T, Tobet SA, Majdic G: Gonadal hormone independent sex differences in steroidogenic factor 1 knockout mice brain. Slov Vet Zb 2010, 47: 167–170.
Budefeld T, Tobet SA, Majdic G: Altered position of cell bodies and fibers in the ventromedial region in SF-1 knockout mice. Exp Neurol 2011, 232: 176–184.
Grgurevic N, Budefeld T, Rissman EF, Tobet SA, Majdic G: Aggressive behaviors in adult SF-1 knockout mice that are not exposed to gonadal steroids during development. Behav Neurosci 2008, 122: 876–884.
Grgurevic N, Budefeld T, Spanic T, Tobet SA, Majdic G: Evidence that sex chromosome genes affect sexual differentiation of female sexual behavior. Horm Behav 2012, 61: 719–724.
Arnold AP: Conceptual frameworks and mouse models for studying sex differences in physiology and disease: why compensation changes the game. Exp Neurol 2014, 259: 2–9.
Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, Rouleau GA, Mechawar N, Turecki G: Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009, 4: e6585.
Luscher B, Shen Q, Sahir N: The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011, 16: 383–406.
Guilloux JP, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K, Tseng GC, Lewis DA, Sibille E: Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry 2012, 17: 1130–1142.
Tripp A, Oh H, Guilloux JP, Martinowich K, Lewis DA, Sibille E: BDNF signaling and subgenual anterior cingulate cortex dysfunction in major depression. Am J Psychiatry 2012, 169: 1194–1202.
Sibille E, Morris HM, Kota RS, Lewis DA: GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol 2011, 14: 721–734.
Seney ML, Chang LC, Oh H, Wang X, Tseng GC, Lewis DA, Sibille E: The role of genetic sex in affect regulation and expression of GABA-related genes across species. Front Psychiatry 2013, 4: 104.
Guilloux JP, Seney M, Edgar N, Sibille E: Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J Neurosci Methods 2011, 197: 21–31.
Hisasue S, Seney ML, Immerman E, Forger NG: Control of cell number in the bed nucleus of the stria terminalis of mice: role of testosterone metabolites and estrogen receptor subtypes. J Sex Med 2010, 7: 1401–1409.
Murray EK, Hien A, de Vries GJ, Forger NG: Epigenetic control of sexual differentiation of the bed nucleus of the stria terminalis. Endocrinology 2009, 150: 4241–4247.
del Abril A, Segovia S, Guillamon A: The bed nucleus of the stria terminalis in the rat: regional sex differences controlled by gonadal steroids early after birth. Brain Res 1987, 429: 295–300.
Guillamon A, Segovia S, del Abril A: Early effects of gonadal steroids on the neuron number in the medial posterior region and the lateral division of the bed nucleus of the stria terminalis in the rat. Brain Res Dev Brain Res 1988, 44: 281–290.
Goel N, Bale TL: Organizational and activational effects of testosterone on masculinization of female physiological and behavioral stress responses. Endocrinology 2008, 149: 6399–6405.
Viau V, Meaney MJ: Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology 1991, 129: 2503–2511.
Laplant Q, Chakravarty S, Vialou V, Mukherjee S, Koo JW, Kalahasti G, Bradbury KR, Taylor SV, Maze I, Kumar A, Graham A, Birnbaum SG, Krishnan V, Truong HT, Neve RL, Nestler EJ, Russo SJ: Role of nuclear factor kappaB in ovarian hormone-mediated stress hypersensitivity in female mice. Biol Psychiatry 2009, 65: 874–880.
Frye CA, Seliga AM: Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn Affect Behav Neurosci 2001, 1: 371–381.
De Vries GJ: Minireview: sex differences in adult and developing brains: compensation, compensation, compensation. Endocrinology 2004, 145: 1063–1068.
Palaszynski KM, Smith DL, Kamrava S, Burgoyne PS, Arnold AP, Voskuhl RR: A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 2005, 146: 3280–3285.
Bonthuis PJ, Cox KH, Rissman EF: X-chromosome dosage affects male sexual behavior. Horm Behav 2012, 61: 565–572.
Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, Jones EG: Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 2005, 102: 15653–15658.
Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF: Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004, 61: 705–713.
Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH: Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999, 56: 1043–1047.
Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC: Anterior cingulate cortex gamma-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry 2012, 69: 139–149.
Tripp A, Kota RS, Lewis DA, Sibille E: Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis 2011, 42: 116–124.
Cowen PJ, Parry-Billings M, Newsholme EA: Decreased plasma tryptophan levels in major depression. J Affect Disord 1989, 16: 27–31.
Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V: “Serotonin depression”—a biochemical subgroup within the affective disorders? Science 1976, 191: 478–480.
Arango V, Underwood MD, Mann JJ: Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 2002, 136: 443–453.
Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, Gardier AM, Dranovsky A, David DJ, Beck SG, Hen R, Leonardo ED: 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65: 40–52.
Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, Guiard BP, Beck SG, Hen R, Leonardo ED: Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 2011, 31: 6008–6018.
Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, Tateno Y: D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berl) 1992, 106: 14–18.
Dougherty DD, Bonab AA, Ottowitz WE, Livni E, Alpert NM, Rauch SL, Fava M, Fischman AJ: Decreased striatal D1 binding as measured using PET and [11C] SCH 23,390 in patients with major depression with anger attacks. Depress Anxiety 2006, 23: 175–177.
Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC: Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C] NNC-112. Neuropsychopharmacology 2009, 34: 1277–1287.
Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J, Kim SY, Adhikari A, Thompson KR, Andalman AS, Gunaydin LA, Witten IB, Deisseroth K: Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013, 493: 537–541.
Seney ML, Ekong KI, Ding Y, Tseng GC, Sibille E: Sex chromosome complement regulates expression of mood-related genes. Biol Sex Differ 2013, 4: 20.